These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 4215428)

  • 1. Qualitative characteristics of anti-DNA antibodies in lupus nephritis.
    Gershwin ME; Steinberg AD
    Arthritis Rheum; 1974; 17(6):947-54. PubMed ID: 4215428
    [No Abstract]   [Full Text] [Related]  

  • 2. Further observations on the treatment of lupus nephritis with prednisone and combined prednisone and azathioprine.
    Donadio JV; Holley KE; Wagoner RD; Ferguson RH; McDuffie FC
    Arthritis Rheum; 1974; 17(5):573-81. PubMed ID: 4278104
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of normalization of serum complement and anti-DNA antibody on the course of lupus nephritis: a two year prospective study.
    Appel AE; Sablay LB; Golden RA; Barland P; Grayzel AI; Bank N
    Am J Med; 1978 Feb; 64(2):274-83. PubMed ID: 629276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reactivities to horse anti-lymphocyte globulin. II. Serum sickness nephritis with complement alterations in man.
    Gewurz H; Pickering RJ; Moberg A; Simmons RL; Good RA; Najarian JS
    Int Arch Allergy Appl Immunol; 1970; 39(2-3):210-20. PubMed ID: 4990556
    [No Abstract]   [Full Text] [Related]  

  • 5. Treatment of systemic lupus erythematosus in childhood.
    Jacobs JC
    Arthritis Rheum; 1977 Mar; 20(2 Suppl):304-7. PubMed ID: 318122
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of the native DNA-binding assay for DNA antibodies in systemic lupus erythematosus and other connective tissue diseases.
    Webb J; Whaley K
    Med J Aust; 1974 Aug; 2(9):324-8. PubMed ID: 4609286
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunological studies concerning the nephritis of systemic lupus erythematosus.
    Koffler D; Schur PH; Kunkel HG
    J Exp Med; 1967 Oct; 126(4):607-24. PubMed ID: 4168098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Systemic lupus erythematosus glomerulonephritis in children.
    Garin EH; Shulman ST; Donnelly WH; Richard GA
    Paediatrician; 1981; 10(5-6):351-67. PubMed ID: 6460214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reassessment of the clinical significance of native DNA antibodies in systemic lupus erythematosus.
    Miniter MF; Stollar BD; Agnello V
    Arthritis Rheum; 1979 Sep; 22(9):959-68. PubMed ID: 314292
    [No Abstract]   [Full Text] [Related]  

  • 10. Antibodies to dAT detected by membrane filtration.
    Lentz K; Winfield JB; Barland P
    Arthritis Rheum; 1976; 19(5):867-73. PubMed ID: 1085627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of therapeutic and immunosuppressive effects of azathioprine, prednisolone and combined therapy in NZP-NZW mice.
    Hahn BH; Bagby MK; Hamilton TR; Osterland CK
    Arthritis Rheum; 1973; 16(2):163-70. PubMed ID: 4123760
    [No Abstract]   [Full Text] [Related]  

  • 12. [Clinical studies on anti-nuclear factor in the patients with systemic lupus erythematosus concerning possible role on pathogenesis].
    Kurata N
    Rinsho Ketsueki; 1972 Aug; 13(4):527-34. PubMed ID: 4539473
    [No Abstract]   [Full Text] [Related]  

  • 13. Pathogenic role of anti-DNA antibodies in murine lupus nephritis.
    Granholm NA; Graves K; Izui S; Cavallo T
    J Clin Lab Immunol; 1985 Nov; 18(3):113-8. PubMed ID: 3878885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The significance of C3 and C4 complement levels in lupus nephritis.
    Levo Y; Pick AI
    Int Urol Nephrol; 1974; 6(3-4):233-8. PubMed ID: 4549215
    [No Abstract]   [Full Text] [Related]  

  • 15. The clinical course of lupus nephritis: relationship to the renal histologic findings.
    Pollak VE; Pirani CL; Dujovne I; Dillard MG
    Perspect Nephrol Hypertens; 1973; 1 Pt 2(0):1167-81. PubMed ID: 4139685
    [No Abstract]   [Full Text] [Related]  

  • 16. Hydralazine therapy in hypertensive patients with idiopathic systemic lupus erythematosus.
    Reza MJ; Dornfeld L; Goldberg LS
    Arthritis Rheum; 1975; 18(4):335-8. PubMed ID: 50845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Studies on differing complement-fixing properties of antinuclear antibodies in the nephropathy of systemic lupus erythematosus].
    Tojo T; Miyachi K; Homma M
    Nihon Naika Gakkai Zasshi; 1972 Jun; 61(6):621-30. PubMed ID: 4565168
    [No Abstract]   [Full Text] [Related]  

  • 18. [Detection of antibodies to soluble nucleoprotein and to deoxyribonucleic acid using a radioimmunologic method].
    Robitaille P
    Union Med Can; 1974 Apr; 103(4):691-8. PubMed ID: 4210048
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical significance of antinuclear antibodies with hypocomplementemia.
    Morris JL; Zizic TM; Shulman LE; Stevens MB
    Johns Hopkins Med J; 1973 Dec; 133(6):321-8. PubMed ID: 4543273
    [No Abstract]   [Full Text] [Related]  

  • 20. Cold-insoluble complexes and complement levels in systemic lupus erythematosus.
    Stastny P; Ziff M
    N Engl J Med; 1969 Jun; 280(25):1376-81. PubMed ID: 4181609
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.